Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon

Recaps

I Can Extract Side Effects
VolumesArcsSummaries

Arc 13Smartwatches and Neural Regeneration

Wei Kang’s ECG technology became the foundation for major smartwatch partnerships and life-saving devices, while Sanqing advanced a neural regeneration drug toward clinical trials. The arc ended with pharmaceutical executives abandoning their own research after learning that Three Purities had already developed a drug.

  • Wei Kang patented the Portable Monitoring Module and formed a medical devices division, where Lu Tingfeng’s heart attack demonstrated the fitness band’s early-warning value.
  • Sanqing’s wristband and Longtu APP attracted Huawei, Rice, OPPO, VIVO, and Apple, though Apple struggled to match the module’s readings and could not access Sanqing’s diagnostic algorithm.
  • Huawei launched smartwatches using Sanqing’s technology, and rescue stories from a subway platform and an Everest expedition helped drive broad public interest and sales.
  • Wei Kang agreed to work with the Aerospace Center on a portable astronaut health-monitoring device, while Apple and Samsung sought Sanqing’s ECG technology and were rebuffed.
  • Chen Yiqing reported that Sanqing had developed a drug activating dormant neural stem cells, and Wei Kang approved publication and further research.
  • Wei Kang approved Wenren Long’s HIV treatment plan, which used CCR5 antagonists while also having him assist Tang Que’s gene-editing work.
  • Chen Yiqing’s brain neuron regeneration paper appeared as a Cell cover article, and researchers worldwide replicated his results while Sanqing’s Neural Regeneration Factor entered Phase I trials in China.
  • Davis gathered pharmaceutical executives after learning of Sanqing’s clinical trial, but they said their own research had failed and abandoned the field.
Chapters 301–325 Vol. 4 Read

Ch. 301Portable Monitoring Device

Wei Kang examined a system prize blueprint for a compact Portable Monitoring Device module that enabled dynamic ECG monitoring. He decided to approach domestic phone manufacturers about integrating it into their smartwatches, then scanned the design and locked the blueprint away.

  • Wei Kang learned that the silver prize was a beginner-level Portable Monitoring Device module for dynamic ECG monitoring, with other functions available for upgrades using points.
  • Wei Kang studied the compact module and considered how it could provide professional-grade heart monitoring when integrated into a smartwatch.
  • Wei Kang decided not to establish a consumer electronics subsidiary and instead chose to seek partnerships with domestic phone manufacturers.
  • Wei Kang scanned the blueprint into his computer, saved the electronic document, and locked the original in a safe.
Read chapter

Ch. 302Testing It Out

Wei Kang built a team to develop and test a wearable ECG monitoring module that could be licensed to device manufacturers. After the first fitness-band prototypes arrived, division head Lu Tingfeng began testing one, but a sharp pain suddenly struck his shoulder as he headed to a meeting.

  • Wei Kang patented the Portable Monitoring Module and formed an Electronics and Medical Devices Division to develop prototype hardware and software.
  • Lu Tingfeng joined Sanqing Group to lead the division and recruited engineers to build and test the wearable monitoring project.
  • The division received its first batch of fitness-band samples, and Lu Tingfeng told employees to wear them continuously and record ECG data.
  • Lu Tingfeng put on a red band and went about his work, intending to bring a sample to Wei Kang for testing.
  • As Lu Tingfeng reached the office entrance on his way to the meeting, a sharp pain shot through his shoulder and he cried out.
Read chapter

Ch. 303Bracelet Alarm: You Have a Heart Attack

Lu Tingfeng’s fitness bracelet warned him that he might have a myocardial infarction, and a hospital ECG confirmed the diagnosis. As he faced urgent treatment, the doctor praised the bracelet and urged Sanqing Group to develop medical equipment that could challenge expensive imported devices.

  • Lu Tingfeng dismissed his brief shoulder pain as fatigue, but Wei Kang noticed a warning light on his fitness bracelet and helped him recognize its myocardial-infarction alert.
  • Wei Kang told Lu Tingfeng to go to the hospital immediately and ordered him not to return to work until a doctor approved.
  • At the hospital, Lu Tingfeng demonstrated the bracelet to a cardiologist, who performed an 18-lead ECG after hearing about its warning.
  • The doctor confirmed that Lu Tingfeng had a myocardial infarction and said he needed cardiac enzyme tests and immediate hospitalization.
  • After learning the bracelet was a Sanqing Group sample, the doctor praised it and complained about hospitals’ reliance on expensive imported medical equipment.
Read chapter

Ch. 304Everyone in the Company Gets One

After Lu Tingfeng’s wristband alerts him to a heart problem, he survives a myocardial infarction and his colleagues become convinced the device can save lives. Wei Kang orders wristbands for the whole company, then promises Jian Lianyun that Three Purities will eventually develop a surgical robot, though he privately doubts he can do so without help from the system.

  • Lu Tingfeng’s subordinates learned he had been rushed to the emergency room, and doctors saved him by dissolving a blood clot before bringing him back to the ward.
  • Lu Tingfeng’s colleagues credited the wristband’s early warning for getting him to the hospital in time and decided to work harder to bring the device to market.
  • After hearing about Lu Tingfeng’s heart attack, Wei Kang ordered the Medical Device Division to obtain enough wristbands for every company employee and to supply samples for the AI Cardiac Diagnostic Algorithm.
  • Employees discussed Lu Tingfeng’s rescue on the company forum, while Wei Kang saw their enthusiasm and began considering partnerships with wearable-device manufacturers.
  • Wei Kang gave Jian Lianyun a wristband, and she praised its health-monitoring features before telling him about the expensive Da Vinci Surgical Robot at her hospital.
  • Jian Lianyun urged Wei Kang to develop a domestic surgical robot, and he promised Three Purities would do so while privately wishing the system would let him draw one.
Read chapter

Ch. 305Red-Hot Across the Internet, but Nowhere to Buy

After recovering, Lu Tingfeng returned to work and helped Wei Kang decide to register the Longtu APP as standalone medical-device software, letting smart wearable manufacturers avoid registering their hardware. Three Purities’ employee fitness bands drew attention online after detecting serious health conditions, and Sanqing Group announced the Longtu APP’s health-monitoring functions, though the product was not yet available to buy.

  • Lu Tingfeng returned from the hospital and discussed medical-device registration with Wei Kang, who chose to apply for the Longtu APP as standalone software.
  • Lu Tingfeng’s team submitted the mobile and wearable versions of the Longtu APP to the provincial Drug Administration Bureau as Class II medical devices.
  • Three Purities employees posted accounts of their fitness bands detecting conditions such as Paroxysmal Atrial Fibrillation, and hundreds of employees and relatives reportedly received alerts.
  • Netizens debated the bands’ accuracy and asked when they could buy them, while many doubted that medical-device approval would come soon.
  • Sanqing Group announced that it had developed the Portable Monitoring Device module and the Longtu APP’s health-monitoring functions.
Read chapter

Ch. 306Mobile Manufacturers: Actions Speak Louder Than Interest

Sanqing clarified that it planned to supply health-monitoring hardware and software rather than make smart wearables, then released impressive wristband test results. Huawei, Rice, OPPO, and VIVO quickly sought cooperation, leaving Wei Kang eager to work with them.

  • Sanqing announced that it would focus on supplying wearable hardware and software, and reported high accuracy for its wristband ECG monitoring and heart-disease diagnosis tests.
  • Yu Dong showed the results to Cai Peng, and Huawei's executives decided to contact Sanqing about integrating the ECG function into their smartwatches.
  • Le Jun judged Sanqing's employee wristband cases to be convincing evidence of its capabilities and called Rice executives to discuss buying a ready-made solution.
  • OPPO and VIVO also contacted Sanqing, joining Huawei and Rice in seeking cooperation.
  • Wei Kang welcomed the approaches and looked forward to working with the four phone manufacturers.
Read chapter

Ch. 307Different Solutions

Four major phone manufacturers evaluated Sanqing Group’s ECG wristband and negotiated access to its technology. They left Sanqing Headquarters after reaching preliminary cooperation agreements, with customized product plans underway.

  • Three days later, representatives from four phone manufacturers gathered at Sanqing Headquarters to review Sanqing’s ECG technology.
  • Lu Tingfeng demonstrated the wristband and Dragon Map APP, and the representatives tested its ECG monitoring and AI heart diagnosis features.
  • Lu Tingfeng explained the medical-device registration requirements and offered manufacturers a combined software-and-hardware solution that let Sanqing assume medical liability.
  • Cai Peng asked whether Dragon Map’s diagnostic results could be integrated into Huawei’s health software, and Lu Tingfeng agreed to share basic results while reserving advanced features for Dragon Map.
  • The four manufacturers developed customized product plans, with Huawei seeking a high-end integration and Rice adapting Sanqing’s wristband solution for its own products.
  • After a week of negotiations, the representatives left Sanqing Headquarters with preliminary cooperation agreements.
Read chapter

Ch. 308Apple Comes Calling, Hardware Only

Cook sent Kevin to China to negotiate with Sanqing Group for its ECG monitoring hardware, while Huawei prepared a feature-rich smartwatch using the technology. At a subway station, Cai Peng used the watch to identify the cause of an unconscious girl's fainting, astonishing the bystanders.

  • Cook reviewed Sanqing Group's ECG sensor reports and sent Kevin to China to negotiate a partnership.
  • Kevin tested Sanqing's sample wristband, praised its ECG module, and agreed that Apple would buy the hardware and data interface without Sanqing's software.
  • Huawei completed smartwatch samples featuring Sanqing's health-detection technology, and Cai Peng proudly wore one.
  • Cai Peng found an unconscious girl on a subway platform and used his smartwatch to check her condition.
  • The watch diagnosed the girl with Supraventricular Paroxysmal Tachycardia, and bystanders searched the condition and marveled at the result.
Read chapter

Ch. 309Measurement Inaccurate? It Must Be Three Purities' Problem

Cai Peng’s Huawei GT4 wristband helped revive a woman who fainted in a subway station, attracting a crowd eager to buy it. Meanwhile, Apple’s Kevin blamed Three Purities’ ECG sensor for inaccurate test results and ordered his team to demand improvements and compensation.

  • Cai Peng showed bystanders the wristband’s rescue instructions, and a middle-aged woman used one to revive the unconscious girl by stimulating her throat.
  • The girl said she had fainted after eating little and drinking coffee, thanked Cai Peng and the woman, and agreed to go to the hospital.
  • Bystanders crowded around Cai Peng with questions about the Huawei GT4, and he said it was still in testing and would likely launch in several months.
  • Subway staff dispersed the crowd, and Cai Peng realized he was late for an exhibition and hurried onto a train.
  • Kevin and Apple’s R&D staff compared the ECG sensor’s readings with a professional monitor, blamed Three Purities for the discrepancies, and extended their tests.
  • After several more days of testing still failed to meet Apple’s requirements, Kevin ordered his team to demand improvements and compensation from Three Purities.
Read chapter

Ch. 310It's Your Problem

A viral subway rescue made the public eager for smartwatches with medical features, while major manufacturers announced products using Sanqing technology. At Sanqing headquarters, Apple engineers investigated a measurement discrepancy and learned that Sanqing’s ECG hardware outperformed their expectations, though its diagnostic algorithm remained proprietary.

  • A video showed a Huawei smartwatch guiding passersby through reviving a collapsed woman, sending the rescue viral and making Huawei’s watch the top trending topic.
  • Le Jun announced Rice’s medical-grade fitness bracelet, and OPPO and VIVO soon promoted their own smartwatches with ECG monitoring and heart-diagnosis features.
  • Netizens concluded that the four manufacturers were using technology supplied by Three Purities, then argued over which watch they would buy.
  • Lu Tingfeng received a complaint from Apple, and Apple engineers visited Sanqing headquarters to investigate discrepancies in ECG readings.
  • Wang Dali explained that Apple’s software needed adjustment for Sanqing’s more accurate monitoring module and demonstrated its results against an 18-lead ECG machine.
  • Apple’s engineers accepted the hardware’s accuracy but could not obtain Sanqing’s proprietary heart-diagnosis algorithm.
Read chapter

Ch. 311Climbing Mount Everest with a Watch

Cai Peng and Yu Dong agreed to develop a cold-resistant, long-lasting Huawei smartwatch for Li Chaoyang’s Mount Everest expedition, where it could monitor climbers’ health. After Huawei delivered the custom watches, Li announced his climb online, and attention shifted to whether he could break the record as the oldest person to summit.

  • Cai Peng met Li Chaoyang, who asked Huawei to customize smartwatches for an Everest climb with older entrepreneurs.
  • Cai Peng proposed low-temperature batteries, waterproofing, longer standby time, group alerts, and medical monitoring, and Yu Dong approved the project.
  • More than half a month later, Huawei delivered watches that worked at minus forty degrees Celsius, and Li Chaoyang and the other climbers put them on in Nepal.
  • Li Chaoyang arrived at Everest’s foot with the expedition and aimed to break the record for the oldest person to summit.
  • Li Chaoyang announced the climb online and posted photos of the smartwatch, prompting widespread discussion about the device, the expedition, and his chances of breaking the record.
Read chapter

Ch. 312Livestreaming the Summit, Smartwatch Shows Its Prowess

Zhang Jun followed Li Chaoyang’s livestream as he climbed Mount Everest with a team using customized Huawei smartwatches to monitor their health and location. After Li Chaoyang fainted from oxygen deprivation at Camp One, he recovered with oxygen, and Zhang Jun and his girlfriend watched as he resumed acclimatization training.

  • Zhang Jun discovered Li Chaoyang’s Mount Everest livestream and watched him demonstrate the customized smartwatch’s team-monitoring features.
  • Li Chaoyang led viewers through Everest Base Camp and explained the team’s fatigue and low-oxygen readings before climbing toward Camp One.
  • Li Chaoyang’s smartwatch alarmed when his heart rate and blood oxygen reached dangerous levels, and he collapsed as the livestream went dark.
  • Li Chaoyang’s teammates gave him oxygen and said he had fainted from oxygen deprivation, while viewers praised the watch and Zhang Jun resolved to buy one.
  • Zhang Jun watched the next day with his girlfriend as Li Chaoyang recovered at camp and began acclimatization training.
Read chapter

Ch. 313Remote Medical Care—Watches Can Do That Too?

Li Chaoyang reached the summit of Mount Everest for a second time with his team, then watched as a smartwatch helped doctors remotely treat the unconscious Boss Duan during their descent. The rescue went viral and drew more attention than Li Chaoyang’s summit record, leaving remote medical care at the center of public discussion.

  • Li Chaoyang reached the Hillary Step and described the final push to his livestream audience before climbing toward the summit.
  • Li Chaoyang and his teammates reached the summit, took photos, and began descending after their watches showed that their conditions were nearing critical levels.
  • At the 6,500-meter camp, Boss Duan lost consciousness, and Captain Huang contacted a base-camp doctor while sending the patient’s smartwatch data and video.
  • The doctor guided the team through emergency treatment remotely, and Boss Duan regained consciousness.
  • A recording of the rescue spread online, and discussion of the smartwatch’s remote medical capabilities overshadowed Li Chaoyang’s summit achievement.
Read chapter

Ch. 314Big Mouth: Our Watches Will Sell Their Way to Number One Worldwide

After the Mount Everest livestream boosted interest in health-monitoring smartwatches, Huawei unveiled its GT4 lineup and detailed its features and prices. Yu Dong predicted Huawei’s watches would become number one worldwide, while Zhang Jun decided to buy the black ceramic GT4 Pro.

  • Li Chaoyang and the others recovered after descending Mount Everest, and the expedition’s livestream brought widespread attention and commercial interest to the watches that had monitored the climbers’ health.
  • On May 27, Zhang Jun watched Yu Dong introduce Huawei’s GT4 lineup and Sanqing Group’s ECG monitoring and AI Heart Diagnosis technology.
  • Yu Dong used a humorous story about a friend taking his watch to illustrate its usefulness during a marathon, drawing laughter from the audience and livestream viewers.
  • Yu Dong presented the five watch models, their features, and their prices, with sales scheduled to begin on June 1.
  • Yu Dong declared that Huawei’s smartwatches would sell their way to number one worldwide, and Zhang Jun resolved to buy the black ceramic GT4 Pro.
Read chapter

Ch. 315The Joy of Taking Apple's Market

Huawei’s GT4 launch drew overwhelming demand, and Yu Dong prioritized domestic supply while celebrating Apple’s decision not to use Sanqing Group’s AI diagnosis software. As Xiaomi, OPPO, and VIVO followed with their own health-monitoring wearables, Wang Guiqing tested a Huawei GT4 Pro and prepared to distribute the watches to special users.

  • Netizens quickly exhausted Huawei’s watch stock, and Cai Peng told Yu Dong that reservations had topped one million in three hours; Yu Dong prioritized domestic orders and delayed overseas sales if necessary.
  • Yu Dong and Cai Peng discussed whether Sanqing Group could supply enough ECG modules and mocked Apple for passing on the Dragon Map App software.
  • Huawei sold more than one million watches on its first night and shipped over three million within days, while Xiaomi launched affordable health-monitoring bracelets and other brands scheduled wearable launches throughout June.
  • The launches brought widespread attention to Sanqing Group’s ECG technology, while Apple users complained that Apple lacked a comparable iWatch and some bought Huawei watches despite reduced compatibility with iPhones.
  • Wang Guiqing received a box of Huawei watches for special users, tested his GT4 Pro, and praised the ECG diagnosis results before preparing to distribute the watches.
Read chapter

Ch. 316Taking the World by Storm, Mabus Wanted to Wear It into Space

Apple CEO Cook gave Kevin three months to improve the iWatch’s heart-diagnosis technology before transferring him to the struggling electric-vehicle department. Meanwhile, Huawei’s GT4 drew acclaim overseas, and Mabus praised its health monitoring on Twitter while imagining wearing it on a spaceflight; FDA chief Davis anticipated pressure to approve the watch.

  • Cook told Kevin that iWatch sales had plunged and gave him three months to make progress before assigning him to Apple’s electric-vehicle department.
  • Kevin explained that Apple lacked the specialist expertise and software needed to match Three Purities’ continuous, detailed ECG diagnosis, so Cook ordered him to poach a professional ECG team.
  • Overseas media and tech bloggers praised Huawei’s GT4, especially its performance during the Mount Everest summit ascent, and eager buyers began seeking the watch.
  • Mabus bought a Huawei GT4 Pro Extreme through an agent, praised its health-monitoring features on Twitter, and said he hoped to wear it into space.
  • Davis noticed that the Huawei watch’s ECG function lacked FDA approval for use in Eagle Country but expected influential customers to push for a faster approval process.
Read chapter

Ch. 317Smartwatches Continue Saving Users Around the World

Juwai smartwatches detected serious health problems in users in China and overseas, helping them seek treatment before their conditions became fatal. The stories spread online and in a popular report, driving another surge in Chinese smartwatch sales.

  • Li Juan's coworker used a Juwai smartwatch to identify her fulminant myocarditis, and Li Juan survived after emergency treatment and a week of recovery.
  • Li Juan's coworker posted the story online, prompting netizens to share other smartwatch-assisted emergencies and encouraging more people to buy watches.
  • Juwai watches launched overseas and sold out on Amazon in Eagle Country within a day as international users praised their design and health features.
  • Short followed his wife's advice to get checked after his watch warned of a high heart rate and possible hypothyroidism, and a doctor confirmed his condition was serious.
  • Jason sought medical care after his Juwai GT4 repeatedly warned him of possible arterial blockage, and treatment eventually restored his health.
  • A report titled "Lives Saved by Smartwatches" went viral, and sales of Chinese smartwatches soared.
Read chapter

Ch. 318Sudden Death Statistics, Visitors from Aerospace

Wei Kang reviewed smart-watch data showing the scale of sudden death and how alerts had helped many users seek treatment, then reflected on the danger faced by young people. After Academician Xie and Fang Heng proposed using Sanqing’s watches for astronauts and developing a portable universal patient monitor, Wei Kang agreed to cooperate with the Aerospace Center, beginning with space tests of the ECG function.

  • Wei Kang studied Longtu APP statistics on sudden death, noting both the high incidence among young people and the many users whose watch alerts prompted them to seek care.
  • Wei Kang spoke with Academician Xie, who introduced Fang Heng from the Aerospace Center and their plan to have astronauts wear smart watches on the Space Station.
  • Fang Heng described the need for real-time astronaut health monitoring and proposed a portable device that could track six vital signs in demanding environments.
  • Wei Kang agreed that Sanqing Group and the Aerospace Center would jointly develop the device, starting by testing the watch’s ECG function in space.
Read chapter

Ch. 319Global Shipment Leader, Big Mouth's Boast Came True Again

Huawei’s smartwatch sales surged to the top of the global market, while Samsung and Apple struggled to obtain or develop the Three Purities’ ECG technology. The chapter ended with Cook ordering Apple to acquire a leading cardiac-monitoring company after the Three Purities rejected its customization demands.

  • A tech influencer reported that Huawei sold more smartwatches in three months than the entire global market shipped, and Yu Dong confirmed sales of 30.89 million units, mostly in China.
  • A tech blogger compared Huawei’s sales with industry shipments and highlighted the scale of Huawei’s lead, prompting widespread celebration online.
  • Lee Jae-yong ordered Samsung to seek the Three Purities’ ECG technology, but the Three Purities rejected the request again, leaving him to consider developing or buying it elsewhere.
  • Kevin told Cook that Apple’s independent diagnostic-software development had failed, so Cook agreed to adopt the Three Purities’ software while continuing Apple’s own research.
  • The Three Purities rejected Apple’s demands for expanded data access and customization, so Cook ordered Kevin to acquire the best cardiac-monitoring company and its technology.
Read chapter

Ch. 320A Major Breakthrough in Neural Stem Cells

Wei Kang learned that Chen Yiqing’s team had developed a drug to activate dormant neural stem cells, raising hopes of repairing brain damage and treating severe neurodegenerative diseases. He then faced a dispute between Tang Que and Wenren Long over competing plans to develop a complete cure for HIV.

  • Chen Yiqing explained how Sanqing’s three years of research had produced a drug that activated dormant neural stem cells and succeeded in mouse experiments.
  • Wei Kang praised Chen Yiqing’s breakthrough and urged him to publish the research and continue toward clinical trials.
  • Chen Yiqing left to return to work, while Wei Kang reviewed the competing proposals for the HIV Infection Complete Cure Plan.
  • Wei Kang recalled that Tang Que and Wenren Long had clashed over which approach to targeting CCR5 could best cure HIV, and prepared to hear their plans before making the final decision.
Read chapter

Ch. 321HIV Cure Strategies: A Battle of Approaches

Wei Kang had Tang Que and Wenren Long present competing strategies for curing HIV. Wenren Long’s CCR5 antagonist plan was approved for development, while Tang Que began considering the difficult task of removing HIV gene fragments from infected cells.

  • Tang Que proposed knocking out CCR5 in patients’ stem cells, but Wenren Long warned that losing CCR5 could weaken defenses against other diseases and leave HIV reservoirs untouched.
  • Wei Kang suggested directly removing HIV gene fragments from patients’ DNA, and Tang Que began examining the technical and financial challenges.
  • Wenren Long proposed using a virus to deliver gene-editing drugs throughout the body, leaving Tang Que impressed but wary of the plan’s difficulty.
  • Wenren Long presented a less aggressive strategy using highly effective CCR5 antagonists, potentially combined with other HIV drugs.
  • Wei Kang approved Wenren Long’s plan and told him to help Tang Que work on the gene-editing approach.
Read chapter

Ch. 322A Cell Paper That Triggered a Massive Shock

Chen Yiqing submitted his paper on neural stem cell regeneration to Cell, and Editor-in-Chief Sweet recognized the discovery’s extraordinary significance. Sweet sent the paper to two experts for review and hoped to publish it as a cover story the following month.

  • Chen Yiqing wrote a paper on brain neuron regeneration and emailed it to Dr. Sweet at Cell.
  • Chen Yiqing put the submission out of his mind and returned to work, expecting the review process to take time.
  • Dr. Sweet noticed Chen Yiqing’s email and was stunned by the paper’s results.
  • Dr. Sweet recognized Sanqing as the research institution and recalled Chen Yiqing from the Lasker Award ceremony, dismissing his initial suspicions of fraud.
  • Dr. Sweet forwarded the paper to two experts in regenerative science and neuroscience and planned to urge them to review it quickly.
Read chapter

Ch. 323A Cell Paper Sparks a Massive Earthquake (Part 2)

Sudehoff tested Chen Yiqing’s paper and found its experiment compelling, while Cell rapidly accepted the work as a cover article. After the issue revealed a method for activating brain stem-cell regeneration, the discovery stunned scientists and sparked global excitement and speculation about whether Sanqing Group would develop a drug.

  • Sudehoff received Chen Yiqing’s manuscript from Cell, rushed to his laboratory before dawn, and began an experiment to verify its findings.
  • Chen Yiqing learned that his paper had passed editorial review and would appear on the cover of the next Cell issue, then told Wei Kang.
  • Cell published the cover article two weeks later, and Professor Duren recognized his former student Lily Zhang as its second author and wrote to congratulate her.
  • The discovery spread worldwide and became a Chinese trending topic, prompting netizens to debate whether Sanqing Group had developed a brain-regeneration drug and whether ordinary people would be able to obtain it.
Read chapter

Ch. 324Confidential Patents, Friendly Nations' Liver Pain

Director Deng moved to classify Sanqing Group’s brain neural stem cell patent as confidential, while officials in Kun City confirmed the company’s Neural Regeneration Factor had begun clinical trials. Western researchers replicated Chen Yiqing’s experiments and rushed to catch up, frustrated that the paper withheld details of how the regulatory genes worked.

  • Director Deng learned that Three Purities had filed a brain neural stem cell patent and ordered it examined as a confidential patent, with all of the company’s patents specially recorded.
  • Director Xie confirmed that Sanqing Group’s Neural Regeneration Factor had received approval for a Phase I clinical trial at Kun City’s First People’s Hospital and said patients registered through the Longtu APP.
  • A caller told Director Xie that Capital City doctors would go to Kun City’s First People’s Hospital for training and resource support.
  • Neuroscience researchers at Western universities and research institutions replicated Chen Yiqing’s experiments, confirmed the existence of human brain neural stem cells, and worked to discover how their regulatory genes functioned.
Read chapter

Ch. 325Multinational Pharmaceutical Companies That Took the Mockery Lying Down

At FDA headquarters, Davis summoned major pharmaceutical companies after learning Three Purities Group had applied for a clinical trial of its neural regeneration drug. The executives admitted they could not reproduce Three Purities’ progress and abandoned the research, leaving Davis to hope academia might succeed.

  • Davis learned from a mysterious caller that Three Purities had applied for a Phase I clinical trial of its Neural Regeneration Factor and was ordered to gather pharmaceutical executives.
  • Davis summoned leaders from Pfizer, Roche, Johnson & Johnson, and other companies to ask about their research into brain neural stem cell regeneration.
  • The executives described years of failed research and said turning Three Purities’ theory into a working drug could take a decade or longer.
  • Davis revealed that Three Purities had already developed a drug and was conducting a clinical trial in China.
  • The Roche and Johnson & Johnson executives announced they were ending research in the field, and the other executives also gave up.
  • Davis watched the executives leave and placed his remaining hope in academic researchers.
Read chapter
Arc 13 of 27
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS